Open original FDA record ↗Recall record
- FDA identifier
- Z-0095-2013
- Company in FDA record
- GE Healthcare, LLC
- FDA classification date
- Oct 19, 2012
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 17, 2026
- Recall classification
- Class II
Reason stated in the source
GE Healthcare has become aware of an issue associated with the magnification images acquired on non-GE digital mammography systems and your Seno Advantage Workstation that may impact patient safety. The measurement values provided by the Seno Advantage Workstation may be incorrect when applied to magnification images acquired on non-GE digital mammography systems. If not noticed by the caregiv
Source facts
- Action
- GE Healthcare sent a Urgent Medical Device Correction letter dated May 23, 2012, to all affected customers. The letter identified the product the problem and the action needed to be taken by the customer. GE Healthcare will install new software to correct this issue with the release of Field Modification Instruction (FMI) 12129 in the near future. This correction will not affect the performance or any other functionality of your current equipment. A GE Healthcare service representative will contact you to arrange for this modification. This activity will be performed at no cost to you. If you have any questions or concerns regarding this notification, please call one of the following phone numbers: United States: 800 437 1171, Japan: 0120 - 055 - 919 For other countries, please contact your local GE Healthcare Service Representative.
- Initiated
- 2012-05-24
- Root cause
- Software design
- Terminated
- 2013-03-26
- Distribution
- Worldwide Distribution--USA (nationwide) including the states of CA, CO, CT, DC, FL, GA, KY,LA, MA, MO, NV, NJ, NY, NC, OH, OK, PA, SD, TN, TX, VA and WI., and the countries of UNITED KINGDOM, TUKEY, TAIWAN, SPAIN, SINGAPORE, SAUDI ARABIA, RUSSIA, PORTUGAL, NEW ZEALAND, NETHERLANDS, MEXICO, MALAYSIA, KOREA, JAPAN, ITALY, HUNGARY, GREECE, GERMANY, FRANCE, CHINA, CANADA, BRAZIL, AUSTRIA and ALGERIA.
- Recall number
- Z-0095-2013
- Recall status
- Terminated
- CDRH record ID
- 108524
- FDA classified
- 2012-10-19
- Recall event number
- 61603